Transjugular intrahepatic portosystemic stent shunt: Indications and long-term outcome;Transjugulärer intrahepatischer portosystemischer stent-shunt: Indikationen und langzeitresultate

Zentralblatt fur Chirurgie

Volumn 130, Issue 3, 2005, Pages 246-249

  Wettstein, Matthias ^a   Luthen R ^b   Cohnen, M ^a   Von Wrisberg, F ^a   Modder U ^a   Haussinger D ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b MARIEN HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Portal hypertension; Refractory ascites; Stent shunt; Variceal bleeding

Indexed keywords

POLITEF;

ASCITES; ESOPHAGUS VARICES BLEEDING; HEPATIC ENCEPHALOPATHY; HUMAN; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; POSTOPERATIVE COMPLICATION; REVIEW; SHUNTING; STENOSIS; SURVIVAL; TREATMENT OUTCOME;

ASCITES; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RECURRENCE; TREATMENT OUTCOME;

EID: 21244466831     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-836547     Document Type: Review

References (27)

1. Richter GM, Noeldge G, Palmaz JC, Roessle M. The transjugular intrahepatic portosystemic stent-shunt (TIPSS): results of a pilot study. Cardiovasc Intervent Radiol 1990; 13: 200-207
2. Rössle M, Haag K, Ochs A, Sellinger M, Noldge G, Perarnau JM, Berger E, Blum U, Gabelmann A, Hauenstein K. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330: 165-171
3. Rössle M, Deibert P, Haag K, Ochs A, Olschewski M, Siegerstetter V, Hauenstein K-H, Siepak C, Keller W, Blum HE. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 1997; 349: 1043-1049
4. Gulberg V, Schepke M, Geigenberger G, Holl J, Brensing KA, Waggershauser T, Reiser M, Schild HH, Sauerbruch T, Gerbes AL. Transjugular intrahepatic portosystemic shunting is not superior to variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial. Scand J Gastroenterol 2002; 37: 338-343
5. Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Scolmerich J. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996; 23: 164-176
6. Ginès P, Arroyo V, Vargas V, Planas R, Casafont F, Panes J, Hoyos M, Viladomiu L, Rimola A, Morillas R. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991; 325: 829-835
7. Bories P, Garcia Compean D, Michel H, Bourel M, Capron JP, Gauthier A, Lafon J, Levy VG, Pascal JP, Quinten A. The treatment of refractory ascites by the LeVeen shunt: a multi-centre controlled trial (57 patients). Hepatology 1986; 3: 212-218
8. Orloff MJ. Pathogenesis and surgical treatment of intractable ascites associated with alcoholic cirrhosis. Ann N Y Acad Sci 1970; 170: 213-238
9. Ochs A, Rössle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, Huonker M, Langer M, Blum HE. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332: 1192-1197
10. Somberg KA, Lake JR, Tomlanovich SJ, LaBerge JM, Feldstein V, Bass NM. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Hepatology 1995; 21: 709-716
11. Lebrec D, Giuily N, Hadengue A, Hadengue A, Vilgrain V, Moreau R, Poynard T, Gadano A, Lassen C, Benhamou JP, Erlinger S. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. J Hepatol 1996; 25: 135-144
12. Nazarian GK, Bjarnason H, Dietz Jr CA, Bernadas CA, Foshager MC, Ferral H, Hunter DW. Refractory ascites: midterm results of treatment with transjugular intrahepatic portosystemic shunt. Radiology 1997; 205: 173-180
13. Rössle M, Ochs A, Gulberg V, Siegerstetter V, Holl J, Olschewski M, Reiser M, Gerbes AL. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000; 342: 1745-1747
14. Rössle M, Siegerstetter V, Huber M, Ochs A. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver 1998; 18: 73-89
15. Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum HE, Rössle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol 2001; 13: 529-534
16. Brensing KA, Textor J, Perz J, Schiedermaier P, Raab P, Strunk H, Klehr HU, Kramer HJ, Spengler U, Schild H, Sauerbruch T. Long term outcome after transjugular intrahepatic portosystemic stent shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000; 47: 288-295
17. Allgaier HP, Haag K, Ochs A, Hauenstein KH, Jeserich M, Krause T, Heilmann C, Gerok W, Rössle M. Hepato-pulmonary syndrome: successful treatment by transjugular intrahepatic portosystemic stent-shunt (TIPS). J Hepatol 1995; 23: 102
18. Blum U, Haag K, Rössle M, Ochs A, Gabelmann A, Boos S, Langer M. Noncavernomatous portal vein thrombosis in hepatic cirrhosis: treatment with transjugular portosystemic shunt and local thrombolysis. Radiology 1995; 195: 153-157
19. Ochs A, Sellinger M, Haag K, Noldge G, Herbst EW, Walter E, Gerok W, Rössle M. Transjugular intrahepatic portosystemic stent shunt (TIPS) in the treatment of Budd-Chiari syndrome. J Hepatol 1994; 21: 685-686
20. Seki S, Sakaguchi H, Kobayashi S, Kitada T, Nakamura K, Yamada R. Transjugular iintrahepatic portosystemic stent shunt in combination with oral anticoagulant for Budd-Chiari-syndrome. Hepatogastroenterology 2001; 48: 1447-1449
21. Zenz T, Rössle M, Bertz H, Siegerstetter V, Ochs A, Kinke J. Severe venoocclusive disease after allogeneic bone marrow or peripheral stem cell transplantation-role of transjugular intrahepatic portosystemic shunt (TIPS). Liver 2001; 21: 31-36
22. Burger JA, Ochs A, Wirth K, Berger DP, Mertelsmann R, Engelhardt R, Rössle M, Haag K. The transjugular stent implantation for the treatment of malignant portal and hepatic vein obstruction in cancer patients. Ann Oncol 1997; 8: 200-202
23. Somberg KA, Lombardero MS, Lawlor SM, Ascher NL, Lake JR, Wiesner RH, Zettermann RK. A controlled analysis of the transjugular intrahepatic portosystemic shunt in liver transplant recipients. Transplantation 1997; 63: 1074-1079
24. Rössle M, Piotraschke J. Transjugular intrahepatic portosystemic shunt and hepatic encephalopathy. Dig Dis 1996; 14: 12-19
25. Bureau C, Garcia-Pagan JC, Otal P, Pomier-Layrargues G, Chabbert V, Cortez C, Perreult P, Peron JM, Abraldes JG, Bouchard L, Bilbao JI, Rousseau H, Vinel JP. Improved clinical outcome using polytetraethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 2004; 126: 469-475
26. Angermayr B, Cejna M, Koenig F, Karnel F, Hackl F, Gangl A, Peck-Radosavljevic M. Vienna TIPS Study Group. Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents. Hepatology 2003; 38: 1043-1050
27. Sze DY, Vestring T, Liddell RP, Kato N, Semba CP, Razavi MK, Kee ST, Dake MD. Recurrent TIPS failure associated with biliary fistulae: treatment with PTFE-covered stents. Cardiovasc Interv Radiol 1999; 22: 298-304